… has high efficacy (99%) for prevention of genital warts. However, a population‐based cohort
… of genital warts in girls aged 14–23 years old. There is no evidence of efficacy against warts …

… Quadrivalent Gardasil shows excellent efficacy against cervical HPV infection, cervical
cancer precursor lesions, and genital warts caused by the HPV types covered by Gardasil [9,11]. …

… are available for the prevention of genital warts and HPV-related anogenital cancers. Given
the challenges associated with treating cutaneous warts, the development of highly effective …

… This work shows that only about 80% in average of genital warts incidence in Catalunya
in the period 2009-2016 was registered, although the frequency of under-reporting has been …

… The incidence of recurrent genital warts is not well characterized; this is especially true in
a … the incidence of subsequent HPV-related external genital warts (EGW) episodes in high-risk …

… We examined trends in rates of genital warts diagnoses and HPV vaccination rates (defined …
to determine genital warts diagnoses. We estimated annual rates of genital warts for each …

… Estimation of the annual number of new precancerous lesions and genital warts … genital
warts was comprehensively described in our previous work [5]. In the present paper we updated …

… Within the genital tract, some diseases have been recognised since antiquity; for example,
genital warts which are caused by HPV types distinct from those causing genital cancer. …

… we identified 9867 (9%) cases of genital warts. Before the vaccine programme started, there
… genital warts. After vaccination began, a decline in number of diagnoses of genital warts …

… For example, genital warts are most often positive for HPV 6 (Greer et al., 1995, Langenberg
et al… While progress has been made in defining the epidemiology and natural history of HPV …